富蘭克林坦伯頓全球投資系列-生技領航基金美元F(acc)股
12.24美元0.19(1.53%)
2024/04/18更新
績效 / 1月7.17%
3月1.22%
1年14.46%
晨星評等-
- 1.現金2.49%
- 2.股票12.39%
- 3.債券0.00%
- 4.其他85.12%
- 1.美國84.51%
- 2.歐洲不包含歐元區3.99%
- 3.歐元區3.77%
- 4.英國3.61%
- 5.加拿大1.03%
- 1.Amgen Inc6.85%
- 2.Regeneron Pharmaceuticals Inc6.43%
- 3.Vertex Pharmaceuticals Inc5.34%
- 4.Ascendis Pharma A/S ADR4.22%
- 5.Gilead Sciences Inc3.07%
- 6.AstraZeneca PLC ADR3.01%
- 7.Biogen Inc2.88%
- 8.Applied Therapeutics Inc2.71%
- 9.Jazz Pharmaceuticals PLC2.67%
- 10.Intra-Cellular Therapies Inc2.62%
- 1.現金2.49%
- 2.股票12.39%
- 3.債券0.00%
- 4.其他85.12%
- 1.美國84.51%
- 2.歐洲不包含歐元區3.99%
- 3.歐元區3.77%
- 4.英國3.61%
- 5.加拿大1.03%
- 1.Amgen Inc6.85%
- 2.Regeneron Pharmaceuticals Inc6.43%
- 3.Vertex Pharmaceuticals Inc5.34%
- 4.Ascendis Pharma A/S ADR4.22%
- 5.Gilead Sciences Inc3.07%
- 6.AstraZeneca PLC ADR3.01%
- 7.Biogen Inc2.88%
- 8.Applied Therapeutics Inc2.71%
- 9.Jazz Pharmaceuticals PLC2.67%
- 10.Intra-Cellular Therapies Inc2.62%